Skobe et al. [30]found VEGF-C from tumor cells could served as a chemoattractant for VEGFR-3–expressing macrophages, which in turn produced more VEGF-C and induced lymphangiogenesis via VEGFR-3 in lymphatic endothelial cells. The gene discussed is VEGFC; the disease is neoplasm.